Suppr超能文献

在固体自微乳化药物传递系统(SMEDDS)制剂中加入可消化表面活性剂可消除滞后时间,并影响消化过程中结构化颗粒的形成。

Inclusion of Digestible Surfactants in Solid SMEDDS Formulation Removes Lag Time and Influences the Formation of Structured Particles During Digestion.

作者信息

Vithani Kapilkumar, Hawley Adrian, Jannin Vincent, Pouton Colin, Boyd Ben J

机构信息

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Parkville, Victoria, 3052, Australia.

SAXS/WAXS Beamtime, Australian Synchrotron, Clayton, Victoria, 3168, Australia.

出版信息

AAPS J. 2017 May;19(3):754-764. doi: 10.1208/s12248-016-0036-6. Epub 2017 Jan 23.

Abstract

Solid self-microemulsifying drug delivery systems (SMEDDS) have received considerable attention in recent times attempting to overcome the drawbacks of liquid SMEDDS. Earlier literature reports on solid SMEDDS have focussed on formulation development; however, the digestibility and propensity for self-assembly of the digested components with endogenous bile salts and phospholipids are unknown. Therefore, as a starting point, previously reported solid SMEDDS containing Gelucire® 44/14 (GEL) and the non-digestible surfactants, Vitamin E TPGS (TPGS) and Lutrol® F 127 (F 127), were prepared, and their dispersion and digestion behaviours were studied using an in vitro lipolysis model, coupled with small-angle X-ray scattering (SAXS) to determine the formed colloidal structures during digestion in real time. GEL alone was digested (89%) and formed a lamellar phase (Lα). When surfactants were added at a 40:60% w/w lipid to surfactants ratio, digestion was inhibited with a significant lag time being evident. However, increasing the fraction of GEL to 50% w/w enabled digestion with reduced lag time. The substitution of the non-digestible surfactants with digestible surfactants, sucrose esters S-1670 (S-1670) and Span® 60 (S-60), eliminated the digestion lag time, and the formation of colloidal structures was more similar to that of GEL alone.

摘要

固体自微乳化药物递送系统(SMEDDS)近来受到了广泛关注,旨在克服液体SMEDDS的缺点。早期关于固体SMEDDS的文献报道主要集中在制剂开发方面;然而,其消化成分与内源性胆汁盐和磷脂的自组装消化率和倾向尚不清楚。因此,作为起点,制备了先前报道的含有Gelucire® 44/14(GEL)以及难消化表面活性剂维生素E TPGS(TPGS)和Lutrol® F 127(F 127)的固体SMEDDS,并使用体外脂解模型结合小角X射线散射(SAXS)研究了它们的分散和消化行为,以实时确定消化过程中形成的胶体结构。单独的GEL被消化(89%)并形成层状相(Lα)。当以40:60% w/w的脂质与表面活性剂比例添加表面活性剂时,消化受到抑制,明显出现显著的延迟时间。然而,将GEL的比例增加到50% w/w可使消化延迟时间缩短。用可消化表面活性剂蔗糖酯S-1670(S-1670)和司盘® 60(S-60)替代难消化表面活性剂,消除了消化延迟时间,并且胶体结构的形成与单独的GEL更相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验